Barnes Group Inc. Mourns the Passing of Board Member Gary G. Benanav

BRISTOL, Conn.--()--Barnes Group Inc. (NYSE: B) today announced the passing of Gary G. Benanav, a longtime member of the Company’s Board of Directors.

“All of us at Barnes Group mourn the loss of Gary Benanav. His valued business insights and steady guidance have greatly contributed to the success of the Company during his more than two decades of service on the Board,” said Thomas O. Barnes, Chairman of the Board of Barnes Group Inc. “We will certainly miss his presence as a talented board member and a dear friend. We offer our deepest sympathies and condolences to Gary’s family.”

Mr. Benanav has been a member of Barnes Group’s Board of Directors since 1994 and has most recently served as a member of the Compensation and Management Development and Corporate Governance Committees. His extensive leadership experience included roles as the Chief Executive Officer of New York Life International, LLC and Vice Chairman and director of New York Life Insurance Company. Mr. Benanav also served as a director of Express Scripts Holding Company, a full-service pharmacy benefit management company and received a Presidential appointment as U.S. representative to the APEC Business Advisory Council where he served from 2002 to 2005.

About Barnes Group

Barnes Group Inc. (NYSE: B) is a global provider of highly engineered products, differentiated industrial technologies, and innovative solutions, serving a wide range of end markets and customers. Its specialized products and services are used in far-reaching applications including aerospace, transportation, manufacturing, automation, healthcare, and packaging. Barnes Group’s skilled and dedicated employees around the globe are committed to the highest performance standards and achieving consistent, sustainable profitable growth. For more information, visit www.BGInc.com.

Contacts

Barnes Group Inc.
William Pitts
Director, Investor Relations
860.583.7070

Contacts

Barnes Group Inc.
William Pitts
Director, Investor Relations
860.583.7070